<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Invitrogen Corporation News</title>
<link>http://www.inboxrobot.com/news/invitrogen-corporation</link>
<description>Constantly updated news and information about a variety of topics.</description><item>
<title>Examine the World Biotechnology Reagents Market</title>
<link>http://www.inboxrobot.com/news.php?fid=206683271</link>
<pubDate>6 Jan 2009 14:14 GMT</pubDate>
<description>
...  Biosciences, Inc., Fitzgerald Industries International, GE Healthcare, Invitrogen Corporation, Ortho-Clinical Diagnostics, Perkin Elmer, Inc., Promega  ...  International (USA) II-60 GE Healthcare (UK) II-60 Invitrogen Corporation (US) II-60 Ortho-Clinical Diagnostics (US) II-61 PerkinElmer,  ...
</description>
</item><item>
<title>High Growth Reported for the World Cell/Tissue Culture Supplies Market</title>
<link>http://www.inboxrobot.com/news.php?fid=206683216</link>
<pubDate>6 Jan 2009 14:14 GMT</pubDate>
<description>
...  Biosciences, Cell Culture Technologies, Cell Essentials, Inc., Invitrogen Corporation, Irvine Scientific, Lonza Biologics Plc, Mediatech,  ...  (Switzerland) II-64 Cell Essentials, Inc. (USA) II-64 Invitrogen Corporation (USA) II-64 Irvine Scientific (USA) II-65 Lonza  ...
</description>
</item><item>
<title>Learn about the World Microplate Instrumentation &amp; Supplies Market</title>
<link>http://www.inboxrobot.com/news.php?fid=206681820</link>
<pubDate>6 Jan 2009 13:51 GMT</pubDate>
<description>
...  Tecan Presents the new CONNECT Microplate Stacker System II-35 7. Recent Industry Activity II-36 Invitrogen Collaborates with Tecan II-36 Kehua and BioMrieux Enter into a Joint Venture II-36 Invitrogen  ...
</description>
</item><item>
<title>Focus on the World Drug Discovery Technologies Market</title>
<link>http://www.inboxrobot.com/news.php?fid=206681289</link>
<pubDate>6 Jan 2009 13:51 GMT</pubDate>
<description>
...  (Formerly Incyte Genomics, Inc.), Infinity Pharmaceuticals, Inc., Invitrogen Corporation, Medarex, Inc., Merck &amp; Co., Inc.,  ...  to Employ Lumi4&amp;trade; Technology of Lumiphore II-53 Invitrogen Corporation Signs Agreement with Emiliem to Screen Kinase  ...
</description>
</item><item>
<title>Key Challenges and Issues Facing the World Gene Amplification Technologies Market</title>
<link>http://www.inboxrobot.com/news.php?fid=206674188</link>
<pubDate>6 Jan 2009 13:12 GMT</pubDate>
<description>
...  and Applera Corporation Expand PCR Licensing Program II-22 Mount and Hamilton Receive Patent II-22 Invitrogen Bags License from Applied Biosystems II-22 OriGene to Access TrueClone II-22 Orchid BioSciences to  ...
</description>
</item><item>
<title>Learn about the World Biochips Market</title>
<link>http://www.inboxrobot.com/news.php?fid=206668297</link>
<pubDate>6 Jan 2009 12:30 GMT</pubDate>
<description>
...  II-43 Biacore Introduces Next Generation System for Protein Interaction Analysis (Sweden) II-44 Affymetrix and Invitrogen Launch Reagents for GeneChip Expression Array Platform II-44 Amersham Biosciences Extends CodeLink Range II-44  ...
</description>
</item><item>
<title>Cancer Cells Escape Chemo Induced Cell Death</title>
<link>http://www.inboxrobot.com/news.php?fid=206640321</link>
<pubDate>6 Jan 2009 08:30 GMT</pubDate>
<description>
...  from cervical, skin, liver and breast cancer tumors. The three apoptotic chemicals were: jasplakinolide (Invitrogen), staurosporine (Sigma) and ethanol (Scharlau). The researchers found that while the chemicals sent the  ...
</description>
</item><item>
<title>Life Technologies to present at t...</title>
<link>http://www.inboxrobot.com/news.php?fid=206472612</link>
<pubDate>5 Jan 2009 11:50 GMT</pubDate>
<description>
...  over 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a  ...
</description>
</item></channel>
</rss>
